Related Experiment Videos

Search for an antidote to electroconvulsion and lethality in aminophylline-sensitized mice

A Chakrabarti1, Y Chugh, P L Sharma

  • 1Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Insights

Aminophylline sensitizes mice to electroshock seizures. Sodium valproate prevents these seizures, while a combination of diazepam and MK-801 offers synergistic protection against aminophylline-induced seizures.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Aminophylline can potentiate seizure susceptibility.
  • Electroconvulsive thresholds can be influenced by pharmacological agents.
  • Understanding drug interactions is crucial for seizure management.

Purpose of the Study:

  • To investigate the neurosensitizing effect of aminophylline on electroconvulsions.
  • To evaluate the protective efficacy of sodium valproate against aminophylline-enhanced seizures.
  • To explore the synergistic potential of diazepam and MK-801 in preventing aminophylline-induced seizures.

Main Methods:

  • Mice were administered diazepam, MK-801, sodium valproate, or combinations thereof.
  • Seizure induction was achieved using corneal electroshock (CES) with varying intensities.
  • Aminophylline was administered to assess its effect on seizure susceptibility and lethality.

Main Results:

  • Diazepam and MK-801 alone protected against high-intensity CES but not aminophylline-potentiated seizures.
  • A combination of diazepam (2.5 mg/kg) and MK-801 (0.25 mg/kg) completely protected against aminophylline + CES-induced seizures and lethality.
  • Sodium valproate (500 mg/kg) demonstrated efficacy against both CES-induced seizures and aminophylline-potentiated seizures.

Conclusions:

  • Aminophylline, at a non-convulsive dose, sensitizes mice to electroconvulsions induced by subthreshold electroshock.
  • Sodium valproate is effective in preventing aminophylline-enhanced seizures.
  • The combination of diazepam and MK-801 exhibits synergistic therapeutic potential against these seizure attacks.

Related Concept Videos